SPT Labtech and 10x Genomics have partnered to provide automated workflows for single cell research. The collaboration will allow scientists to scale experiments on 10x’s Chromium Single Cell platform ...

10x Genomics (TXG-2.25%) has come a long way since opening its doors in 2012. The genomics company now has a market cap of close to $20 billion. In this video recorded on March 11, 2021, Motley Fool ...

10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, and Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, today announced the ...

Arc Institute continues its work to generate and share large-scale, high-quality datasets of cell state before and after chemical or genetic perturbations to enable “virtual cell” models and other ...

10x Genomics reported 18% YoY revenue growth in Q4, reaching $184M, with instruments revenue seeing a remarkable surge of 71%. The company celebrated the successful launch of its cutting-edge platform ...

10x Genomics has been on my Compounding Healthcare “Bio Boom” speculative portfolio watch list since its IPO back in 2019. I believe 10x Genomics is becoming an entrenched name. After performing some ...

SPT Labtech, a pioneer in the design and development of laboratory automation and liquid handling solutions, and 10x Genomics, Inc., a leader in single cell and spatial biology, today announced a ...